160 related articles for article (PubMed ID: 9589642)
1. Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women.
Thompson JL; Butterfield GE; Gylfadottir UK; Yesavage J; Marcus R; Hintz RL; Pearman A; Hoffman AR
J Clin Endocrinol Metab; 1998 May; 83(5):1477-84. PubMed ID: 9589642
[TBL] [Abstract][Full Text] [Related]
2. Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone.
Ellis KJ; Lee PD; Pivarnik JM; Bukar JG; Gesundheit N
J Clin Endocrinol Metab; 1996 Aug; 81(8):3033-8. PubMed ID: 8768870
[TBL] [Abstract][Full Text] [Related]
3. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
Snyder DK; Clemmons DR; Underwood LE
J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
[TBL] [Abstract][Full Text] [Related]
4. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
5. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
[TBL] [Abstract][Full Text] [Related]
6. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
Gleeson HK; Lissett CA; Shalet SM
J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
9. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.
Snyder DK; Clemmons DR; Underwood LE
J Clin Endocrinol Metab; 1989 Oct; 69(4):745-52. PubMed ID: 2778033
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men.
Taaffe DR; Pruitt L; Reim J; Hintz RL; Butterfield G; Hoffman AR; Marcus R
J Clin Endocrinol Metab; 1994 Nov; 79(5):1361-6. PubMed ID: 7525633
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.
Hoffman AR; Kuntze JE; Baptista J; Baum HB; Baumann GP; Biller BM; Clark RV; Cook D; Inzucchi SE; Kleinberg D; Klibanski A; Phillips LS; Ridgway EC; Robbins RJ; Schlechte J; Sharma M; Thorner MO; Vance ML
J Clin Endocrinol Metab; 2004 May; 89(5):2048-56. PubMed ID: 15126520
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.
Franco C; Brandberg J; Lönn L; Andersson B; Bengtsson BA; Johannsson G
J Clin Endocrinol Metab; 2005 Mar; 90(3):1466-74. PubMed ID: 15598680
[TBL] [Abstract][Full Text] [Related]
14. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
Holloway L; Kohlmeier L; Kent K; Marcus R
J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
[TBL] [Abstract][Full Text] [Related]
15. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
[TBL] [Abstract][Full Text] [Related]
16. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.
Tagliaferri M; Scacchi M; Pincelli AI; Berselli ME; Silvestri P; Montesano A; Ortolani S; Dubini A; Cavagnini F
Int J Obes Relat Metab Disord; 1998 Sep; 22(9):836-41. PubMed ID: 9756240
[TBL] [Abstract][Full Text] [Related]
18. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human growth hormone, but not insulin-like growth factor-I, enhances central fat loss in postmenopausal women undergoing a diet and exercise program.
Taaffe DR; Thompson JL; Butterfield GE; Hoffman AR; Marcus R
Horm Metab Res; 2001 Mar; 33(3):156-62. PubMed ID: 11355749
[TBL] [Abstract][Full Text] [Related]
20. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women.
Friedlander AL; Butterfield GE; Moynihan S; Grillo J; Pollack M; Holloway L; Friedman L; Yesavage J; Matthias D; Lee S; Marcus R; Hoffman AR
J Clin Endocrinol Metab; 2001 Apr; 86(4):1496-503. PubMed ID: 11297574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
